Synergies among inhibitory receptors in tolerance, cancer and antiviral immunity

Active Project Grant Awarded Last action

Award ID
P01AI108545
Recipient
Awarding agency
Obligated
$37,272,744

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 75% complete
Originally
Funding
  • $34,962,548.00 Federal
  • $2,310,196.00 Non-federal
Place of performance
Pittsburgh, PA 15222, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment Synergies among inhibitory receptors in tolerance and disease - PPG summary the inhibitory receptors PD1 and LAG3 synergize in the regulation of immune… $2,747,414 $0
Amendment Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity - PPG summary the inhibitory receptors PD1 and LAG3 synergize in the regulation… $0 $0
Amendment $0 $0
Amendment Synergies among inhibitory receptors in tolerance and disease - PPG summary the inhibitory receptors PD1 and LAG3 synergize in the regulation of immune… $2,775,439 $0
Amendment $2,311,666 $0
Amendment $2,311,666 $0
Amendment $2,311,666 $0
Amendment $2,311,666 $0
Amendment $2,311,666 $0
Amendment $2,296,071 $0
Amendment $2,296,071 $2,296,071
Amendment -$30,814 $0
Amendment $30,814 $0
Amendment -$30,814 -$30,814
Amendment $30,814 $30,814
Amendment $14,125 $0
Amendment $14,125 $14,125
Amendment $2,338,887 $0
Amendment $0 $0
Amendment Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity $2,188,670 $0
Amendment $2,178,406 $0
Amendment $2,170,094 $0
Amendment $2,161,524 $0
Original award $2,223,392 $0
Show all 24

Subawards

Subrecipient Amount Awarded
The Trustees Of The University Of Pennsylvania Synergies among inhibitory receptors in tolerance and disease $1,203,802
The Trustees Of The University Of Pennsylvania $509,301
President And Fellows Of Harvard College $1,255,658
Brigham & Womens Hospital Inc. Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity $160,375
The Trustees Of The University Of Pennsylvania $432,549
Harvard College President & Fellows Of $456,302
Brigham & Womens Hospital Inc. $160,375
President And Fellows Of Harvard College $456,302
The Trustees Of The University Of Pennsylvania $210,738
The Trustees Of The University Of Pennsylvania $432,549
The Trustees Of The University Of Pennsylvania $210,738
The Trustees Of The University Of Pennsylvania $432,549
President And Fellows Of Harvard College $456,302
Brigham & Womens Hospital Inc. $160,375
Harvard College President & Fellows Of $456,302
Brigham & Womens Hospital Inc. $160,374
The Trustees Of The University Of Pennsylvania T cell exhaustion is a common feature of chronic infections and cancer that limits effective viral or tumor control. A major breakthrough in this field was… $427,912
President And Fellows Of Harvard College The goal of Project 1 is to elucidate overlapping and unique functions of PD1 and LAG3 on CD4+ FoxP3- T cells and Treg in controlling tolerance and… $453,290
President And Fellows Of Harvard College Synergies among inhibitory receptors in tolerance, cancer and antiviral immunity $23,182
Brigham & Womens Hospital Inc. $93,384
The Trustees Of The University Of Pennsylvania T cell exhaustion is a common feature of chronic infections and cancer that limits effective viral or tumor control. A major breakthrough in this field was… $199,722
Brigham & Womens Hospital Inc. The overall goal of Core 0 is to provide sophisticated and relevant technologies and expertise to program project grant (PPG} investigators for understanding… $94,050
The Trustees Of The University Of Pennsylvania T cell exhaustion is a common feature of chronic infections and cancer that limits effective viral or tumor control. A major breakthrough in this field was… $197,471
The Trustees Of The University Of Pennsylvania T cell exhaustion is a common feature of chronic infections and cancer that limits effective viral or tumor control. A major breakthrough in this field was… $423,547
President And Fellows Of Harvard College The goal of Project 1 is to elucidate overlapping and unique functions of PD1 and LAG3 on CD4+ FoxP3- T cells and Treg in controlling tolerance and… $460,382
Brigham & Womens Hospital Inc. The overall goal of Core 0 is to provide sophisticated and relevant technologies and expertise to program project grant (PPG} investigators for understanding… $96,350
President And Fellows Of Harvard College The goal of Project 1 is to elucidate overlapping and unique functions of PD1 and LAG3 on CD4+ FoxP3- T cells and Treg in controlling tolerance and… $23,919
President And Fellows Of Harvard College $467,689
The Trustees Of The University Of Pennsylvania T cell exhaustion is a common feature of chronic infections and cancer that limits effective viral or tumor control. A major breakthrough in this field was… $419,360
President And Fellows Of Harvard College The goal of Project 1 is to elucidate overlapping and unique functions of PD1 and LAG3 on CD4+ FoxP3- T cells and Treg in controlling tolerance and… $474,988
The Trustees Of The University Of Pennsylvania T cell exhaustion is a common feature of chronic infections and cancer that limits effective viral or tumor control. A major breakthrough in this field was… $415,148
Brigham & Womens Hospital Inc. The overall goal of Core 0 is to provide sophisticated and relevant technologies and expertise to program project grant (PPG} investigators for understanding… $97,854
Show all 32

Quick answers

Who received award P01AI108545?

P01AI108545 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 15, 2015.

How much is award P01AI108545 worth?

$37,272,744 has been obligated on P01AI108545: $34,962,548 in federal funding and $2,310,196 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login